← Leaderboards
Robert James Geraghty
University Of Minnesota
$2,937,593
Attributed
$4,573,843
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $654.5K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,573,843 · 3
By mechanism
R01$4,422,843 · 2
R03$151,000 · 1
Top collaborators
- Zhengqiang Wang5 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Paul James Jardine$3,296,578
- Zhengqiang Wang$10,211,439
- Hideki Aihara$15,628,976
- James R Lokensgard$16,261,665
- Steven E Patterson$9,957,982
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusProteinsDrug KineticsAntiviral AgentsAcquired Immunodeficiency SyndromeCytomegalovirusCostBindingBiochemicalBiochemistryBrain InjuriesAtp PhosphohydrolaseAllograft RejectionCell Culture TechniquesCell FusionActive SitesAnalogComplexCell SurvivalChemistryCidofovirClinicCollaborationsDna Packaging
Grant awards (12)
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein$654,500
R01 · FY2023 · AI · contact PI
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein$654,500
R01 · FY2022 · AI · contact PI
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein$654,500
R01 · FY2021 · AI · contact PI
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein$654,500
R01 · FY2020 · AI · contact PI
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein$654,500
R01 · FY2019 · AI · contact PI
Membrane fusion during HSV-1 entry$75,500
R03 · FY2010 · AI · contact PI
Membrane fusion during HSV-1 entry$75,500
R03 · FY2009 · AI · contact PI
Spread of HSV-1 mediated by the gD receptor nectin-1$251,718
R01 · FY2006 · AI · contact PI
Spread of HSV-1 mediated by the gD receptor nectin-1$257,775
R01 · FY2005 · AI
Spread of HSV-1 mediated by the gD receptor nectin-1$257,600
R01 · FY2004 · AI
Spread of HSV-1 mediated by the gD receptor nectin-1$255,500
R01 · FY2003 · AI
Spread of HSV-1 mediated by the gD receptor nectin-1$127,750
R01 · FY2002 · AI